Portfolio

Mitralign

CEO Rick Geoffrion

Percutaneous transcatheter devices for the treatment of mitral valve regurgitation.

Designs and develops percutaneous transcatheter devices for the treatment of mitral valve regurgitation (a significant factor in congestive heart failure.)

Human Health

Mitralign logo

Industry

Medtech

Status

Past

Location

US